The new contributions of the thesis include a number of clinical and laboratory characteristics of polycythemia vera (PV), essential thrombocythemia (ET), primary myelofibrosis (PMF); rate of mutations in some genes and the relationship between gene mutations and disease progression as well as treatment results.